According to the current guidelines, computed tomography (CT) and bone scintigraphy (BS) are optional in intermediate-risk and recommended in high-risk prostate cancer (PCa). We wonder whether it is time for these examinations to be dismissed, evaluating their staging accuracy in a large cohort of radical prostatectomy (RP) patients.
Is there still a role for computed tomography and bone scintigraphy in prostate cancer staging? An analysis from the EUREKA-1 database
Terrone, C;
2016-01-01
Abstract
According to the current guidelines, computed tomography (CT) and bone scintigraphy (BS) are optional in intermediate-risk and recommended in high-risk prostate cancer (PCa). We wonder whether it is time for these examinations to be dismissed, evaluating their staging accuracy in a large cohort of radical prostatectomy (RP) patients.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Gabriele2016_Article_IsThereStillARoleForComputedTo.pdf
accesso chiuso
Descrizione: Articolo principale
Tipologia:
Documento in versione editoriale
Dimensione
742.42 kB
Formato
Adobe PDF
|
742.42 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
